Related Experiment Video
Updated: Dec 17, 2025
Multi-system Monitoring for Identification of Seizures, Arrhythmias and Apnea in Conscious Restrained Rabbits
Published on: March 27, 2021
Transgenic Rabbit Models in Proarrhythmia Research
István Baczkó1, Tibor Hornyik1,2,3, Michael Brunner2,3,4
1Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
Abstract:
Drug-induced proarrhythmia constitutes a potentially lethal side effect of various drugs. Most often, this proarrhythmia is mechanistically linked to the drug's potential to interact with repolarizing cardiac ion channels causing a prolongation of the QT interval in the ECG. Despite sophisticated screening approaches during drug development, reliable prediction of proarrhythmia remains very challenging. Although drug-induced long-QT-related proarrhythmia is often favored by conditions or diseases that impair the individual's repolarization reserve, most cellular, tissue, and whole animal model systems used for drug safety screening are based on normal, healthy models. In recent years, several transgenic rabbit models for different types of long QT syndromes (LQTS) with differences in the extent of impairment in repolarization reserve have been generated. These might be useful for screening/prediction of a drug's potential for long-QT-related proarrhythmia, particularly as different repolarizing cardiac ion channels are impaired in the different models. In this review, we summarize the electrophysiological characteristics of the available transgenic LQTS rabbit models, and the pharmacological proof-of-principle studies that have been performed with these models-highlighting the advantages and disadvantages of LQTS models for proarrhythmia research. In the end, we give an outlook on potential future directions and novel models.
Insights
Predicting drug-induced proarrhythmia is challenging. Transgenic long QT syndrome (LQTS) rabbit models offer improved prediction by mimicking impaired repolarization reserve, aiding drug safety screening.
Area of Science:
- Cardiovascular Pharmacology
- Cardiac Electrophysiology
- Drug Safety Assessment
Background:
- Drug-induced proarrhythmia, often linked to QT interval prolongation, is a dangerous side effect.
- Current drug screening models typically use healthy subjects, failing to account for impaired repolarization reserve.
- Predicting proarrhythmia risk remains a significant challenge in drug development.
Purpose of the Study:
- To review the utility of transgenic long QT syndrome (LQTS) rabbit models for predicting drug-induced proarrhythmia.
- To summarize the electrophysiological properties and pharmacological studies of existing LQTS rabbit models.
- To highlight the advantages and limitations of LQTS models in proarrhythmia research.
Main Methods:
- Review of electrophysiological characteristics of transgenic LQTS rabbit models.
- Analysis of pharmacological proof-of-principle studies using these models.
- Comparison of different LQTS models with varying degrees of repolarization reserve impairment.
Main Results:
- Transgenic LQTS rabbit models exhibit distinct electrophysiological profiles reflecting impaired repolarization.
- Pharmacological studies demonstrate the potential of these models to identify proarrhythmic drug effects.
- Different LQTS models may be suitable for assessing drugs affecting specific cardiac ion channels.
Conclusions:
- Transgenic LQTS rabbit models represent a valuable tool for improving the prediction of drug-induced proarrhythmia.
- These models offer a more relevant platform for safety screening, especially in the context of compromised repolarization.
- Future research should focus on refining these models and exploring novel approaches for proarrhythmia risk assessment.
